$13.00
0.23% day before yesterday
Nasdaq, Dec 27, 10:00 pm CET
ISIN
US2681582019
Symbol
DVAX

Dynavax Technologies Corporation Stock price

$13.00
+0.09 0.70% 1M
+1.63 14.34% 6M
-0.98 7.01% YTD
-1.13 8.00% 1Y
-1.39 9.66% 3Y
+7.01 117.03% 5Y
-3.32 20.34% 10Y
Nasdaq, Closing price Fri, Dec 27 2024
-0.03 0.23%
ISIN
US2681582019
Symbol
DVAX
Sector
Industry

Key metrics

Market capitalization $1.71b
Enterprise Value $1.20b
P/E (TTM) P/E ratio 99.77
EV/FCF (TTM) EV/FCF 52.91
EV/Sales (TTM) EV/Sales 4.60
P/S ratio (TTM) P/S ratio 6.55
P/B ratio (TTM) P/B ratio 2.51
Revenue growth (TTM) Revenue growth -27.79%
Revenue (TTM) Revenue $260.81m
EBIT (operating result TTM) EBIT $-7.44m
Free Cash Flow (TTM) Free Cash Flow $22.67m
Cash position $763.99m
EPS (TTM) EPS $0.13
P/E forward 65.66
P/S forward 6.17
EV/Sales forward 4.33
Short interest 15.59%
Show more

Is Dynavax Technologies Corporation a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,886 stocks worldwide.

Dynavax Technologies Corporation Stock Analysis

Unlock Scores for Free

Analyst Opinions

6 Analysts have issued a Dynavax Technologies Corporation forecast:

5x Buy
83%
1x Hold
17%

Analyst Opinions

6 Analysts have issued a Dynavax Technologies Corporation forecast:

Buy
83%
Hold
17%

Financial data from Dynavax Technologies Corporation

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
261 261
28% 28%
100%
- Direct Costs 45 45
62% 62%
17%
216 216
11% 11%
83%
- Selling and Administrative Expenses 159 159
9% 9%
61%
- Research and Development Expense 57 57
6% 6%
22%
0.50 0.50
99% 99%
0%
- Depreciation and Amortization 7.94 7.94
17% 17%
3%
EBIT (Operating Income) EBIT -7.44 -7.44
120% 120%
-3%
Net Profit 20 20
66% 66%
8%

In millions USD.

Don't miss a Thing! We will send you all news about Dynavax Technologies Corporation directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Dynavax Technologies Corporation Stock News

Neutral
PRNewsWire
about one month ago
EMERYVILLE, Calif. , Nov. 26, 2024 /PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial-stage biopharmaceutical company developing and commercializing innovative vaccines, today announced that the Company will present at the 7th Annual Evercore HealthCONx Conference on Tuesday, December 3 at 2:35 p.m.
Positive
Seeking Alpha
about 2 months ago
Today, we revisit Dynavax Technologies Corporation, whose shares have moved up nicely after the company announced a significant buyback authorization. In addition, DVAX's flagship product Heplisav-B continues to increase market share consistently in a growing market. The company has also moved towards profitability and analyst firms have price targets significantly above the current trading lev...
Neutral
PRNewsWire
about 2 months ago
EMERYVILLE, Calif. , Nov. 11, 2024 /PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial-stage biopharmaceutical company developing and commercializing innovative vaccines, today announced that it has entered into an Accelerated Share Repurchase transaction ("ASR") under an agreement with Goldman Sachs & Co. LLC to repurchase $100 million of the Company's common stock.
More Dynavax Technologies Corporation News

Company Profile

Dynavax Technologies Corp. operates as a biopharmaceutical company, which engages in the discovery, development and commercialization of novel vaccines and immuno-oncology therapeutics. The firm focuses on leveraging the body's innate and adaptive immune responses through toll-like receptor stimulation. It offers products for vaccines, cancer immunotherapy, and immune-mediated diseases. The company was founded by Lawrence M. Lichtenstein, Dennis A. Carson, and Eyal Raz on August 29, 1996 and is headquartered in Berkeley, CA.

Head office United States
CEO Ryan Spencer
Employees 408
Founded 1996
Website www.dynavax.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today